Everolimus Enhances the Efficacy of Fulvestrant in ER+ Breast Cancer [Research Watch]

mTOR inhibition with everolimus extends progression-free survival in combination with fulvestrant.

from Cancer via ola Kala on Inoreader https://ift.tt/2r5SDe2
via IFTTT